Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Times Interest Earned (2022 - 2023)

Century Therapeutics (IPSC) has disclosed Times Interest Earned for 2 consecutive years, with -$257.92 as the latest value for Q2 2023.

  • Quarterly Times Interest Earned fell 108.96% to -$257.92 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was -$1071.9 through Mar 2024, down 1249.89% year-over-year, with the annual reading at -$271.38 for FY2023, 189.97% down from the prior year.
  • Times Interest Earned for Q2 2023 was -$257.92 at Century Therapeutics, down from -$92.19 in the prior quarter.
  • The five-year high for Times Interest Earned was -$51.8 in Q4 2022, with the low at -$257.92 in Q2 2023.